Literature DB >> 31713830

Infliximab therapy for inflammatory colitis in an infant with NEMO deficiency.

Hasibe Artac1, Ayca Emsen2, Hulya Ucaryilmaz2, Halil Haldun Emiroglu3, Vedat Uygun4, Asbjørg Stray-Pedersen5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31713830     DOI： 10.1007/s12026-019-09100-z

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  14 in total

1.  Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.

Authors:  Arianna Nenci; Marion Huth; Alfred Funteh; Marc Schmidt-Supprian; Wilhelm Bloch; Daniel Metzger; Pierre Chambon; Klaus Rajewsky; Thomas Krieg; Ingo Haase; Manolis Pasparakis
Journal:  Hum Mol Genet       Date:  2006-01-06       Impact factor: 6.150

2.  Infliximab therapy in pediatric patients 7 years of age and younger.

Authors:  Judith R Kelsen; Andrew B Grossman; Helen Pauly-Hubbard; Kernika Gupta; Robert N Baldassano; Petar Mamula
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-12       Impact factor: 2.839

3.  Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency.

Authors:  Tomoyuki Mizukami; Megumi Obara; Ryuta Nishikomori; Tomoki Kawai; Yoshihiro Tahara; Naoki Sameshima; Kousuke Marutsuka; Hiroshi Nakase; Nobuhiro Kimura; Toshio Heike; Hiroyuki Nunoi
Journal:  J Clin Immunol       Date:  2011-10-13       Impact factor: 8.317

Review 4.  Inflammatory bowel disease caused by primary immunodeficiencies-Clinical presentations, review of literature, and proposal of a rational diagnostic algorithm.

Authors:  Daniel Tegtmeyer; Maximilian Seidl; Patrick Gerner; Ulrich Baumann; Christian Klemann
Journal:  Pediatr Allergy Immunol       Date:  2017-08       Impact factor: 6.377

5.  Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation.

Authors:  Jun Yang; Daniel Ka Leung Cheuk; Shau Yin Ha; Alan Kwok Shing Chiang; Tsz Leung Lee; Marco Hok Kung Ho; Godfrey Chi Fung Chan
Journal:  Pediatr Transplant       Date:  2012-08-20

6.  Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

Authors:  Asbjørg Stray-Pedersen; Hanne Sørmo Sorte; Pubudu Samarakoon; Tomasz Gambin; Ivan K Chinn; Zeynep H Coban Akdemir; Hans Christian Erichsen; Lisa R Forbes; Shen Gu; Bo Yuan; Shalini N Jhangiani; Donna M Muzny; Olaug Kristin Rødningen; Ying Sheng; Sarah K Nicholas; Lenora M Noroski; Filiz O Seeborg; Carla M Davis; Debra L Canter; Emily M Mace; Timothy J Vece; Carl E Allen; Harshal A Abhyankar; Philip M Boone; Christine R Beck; Wojciech Wiszniewski; Børre Fevang; Pål Aukrust; Geir E Tjønnfjord; Tobias Gedde-Dahl; Henrik Hjorth-Hansen; Ingunn Dybedal; Ingvild Nordøy; Silje F Jørgensen; Tore G Abrahamsen; Torstein Øverland; Anne Grete Bechensteen; Vegard Skogen; Liv T N Osnes; Mari Ann Kulseth; Trine E Prescott; Cecilie F Rustad; Ketil R Heimdal; John W Belmont; Nicholas L Rider; Javier Chinen; Tram N Cao; Eric A Smith; Maria Soledad Caldirola; Liliana Bezrodnik; Saul Oswaldo Lugo Reyes; Francisco J Espinosa Rosales; Nina Denisse Guerrero-Cursaru; Luis Alberto Pedroza; Cecilia M Poli; Jose L Franco; Claudia M Trujillo Vargas; Juan Carlos Aldave Becerra; Nicola Wright; Thomas B Issekutz; Andrew C Issekutz; Jordan Abbott; Jason W Caldwell; Diana K Bayer; Alice Y Chan; Alessandro Aiuti; Caterina Cancrini; Eva Holmberg; Christina West; Magnus Burstedt; Ender Karaca; Gözde Yesil; Hasibe Artac; Yavuz Bayram; Mehmed Musa Atik; Mohammad K Eldomery; Mohammad S Ehlayel; Stephen Jolles; Berit Flatø; Alison A Bertuch; I Celine Hanson; Victor W Zhang; Lee-Jun Wong; Jianhong Hu; Magdalena Walkiewicz; Yaping Yang; Christine M Eng; Eric Boerwinkle; Richard A Gibbs; William T Shearer; Robert Lyle; Jordan S Orange; James R Lupski
Journal:  J Allergy Clin Immunol       Date:  2016-07-16       Impact factor: 10.793

7.  Deficiency of innate and acquired immunity caused by an IKBKB mutation.

Authors:  Ulrich Pannicke; Bernd Baumann; Sebastian Fuchs; Philipp Henneke; Anne Rensing-Ehl; Marta Rizzi; Ales Janda; Katrin Hese; Michael Schlesier; Karlheinz Holzmann; Stephan Borte; Constanze Laux; Eva-Maria Rump; Alan Rosenberg; Teresa Zelinski; Hubert Schrezenmeier; Thomas Wirth; Stephan Ehl; Marlis L Schroeder; Klaus Schwarz
Journal:  N Engl J Med       Date:  2013-12-26       Impact factor: 91.245

8.  Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity.

Authors:  Eric P Hanson; Linda Monaco-Shawver; Laura A Solt; Lisa A Madge; Pinaki P Banerjee; Michael J May; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2008-10-11       Impact factor: 10.793

9.  Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.

Authors:  J D Fish; R E Duerst; E W Gelfand; J S Orange; N Bunin
Journal:  Bone Marrow Transplant       Date:  2008-09-15       Impact factor: 5.483

Review 10.  Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature.

Authors:  Sima S Toussi; Nancy Pan; Heather M Walters; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2013-07-29       Impact factor: 9.079
View more
  3 in total

1.  Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

Authors:  Holm H Uhlig; Fabienne Charbit-Henrion; Daniel Kotlarz; Dror S Shouval; Tobias Schwerd; Caterina Strisciuglio; Lissy de Ridder; Johan van Limbergen; Marina Macchi; Scott B Snapper; Frank M Ruemmele; David C Wilson; Simon P L Travis; Anne M Griffiths; Dan Turner; Christoph Klein; Aleixo M Muise; Richard K Russell
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-03-01       Impact factor: 3.288

2.  Management of COVID-19 pneumonia in a child with NEMO deficiency.

Authors:  Gulsum Alkan; Hasibe Artac; Sadiye Kubra Tuter Oz; Melike Emiroglu
Journal:  Immunol Res       Date:  2021-06-01       Impact factor: 2.829

3.  Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target.

Authors:  Lauren Mifflin; Dimitry Ofengeim; Junying Yuan
Journal:  Nat Rev Drug Discov       Date:  2020-07-15       Impact factor: 112.288
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.